Article
PIK3CA mutations in hepatocellular carcinoma in Korea.
Yonsei medical journal - 1 Jul 2013
Kim Heesue, Park Cheol-Keun, Lee Su Jin, Rha Sun Young, Park Kyu Hyun, Lim Ho Yeong
Abstract excerpt
PURPOSE: Phosphatidylinositol 3-kinases/AKT pathway plays a pivotal role in hepatocellular carcinoma (HCC). Mutant PIK3CA, encoding the p110a catalytic subunit, stimulates the AKT pathway and promotes cell growth in various cancers. PIK3CA mutation rate has been usually reported as low frequency (<5%) in HCC except one report from Korea with 35.6%. Therefore, we investigated the frequency of PIK3CA mutations in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
